Navigation Links
Complexities of human disease targeted with $16 million in funding
Date:12/18/2012

Scientists at the Walter and Eliza Hall Institute in Melbourne, Australia, have received more than $16 million in Australian Government funding to pursue research into cancer, malaria, rheumatoid arthritis and the immune system, it was announced today.

The funding was announced by federal health minister Tanya Plibersek and will be distributed through the National Health and Medical Research Council. Walter and Eliza Hall Institute scientists were awarded two program grants, worth more than $15 million over five years, two development grants, worth more than $1.3 million; and three PhD scholarships.

The program grants will:

  • support researchers from the Bioinformatics division as they seek to develop new methods for analysing the massive, complex data sets that are generated by biomedical researchers; and
  • help researchers from the Immunology and Molecular Immunology divisions understand how white blood cells make the decisions that influence the strength, type, and longevity of the immunity created when the body encounters a foreign invader.

Professor Phil Hodgkin, who is leading the immunology research program, said it would focus on the adaptive immune response and the role of B cells and T cells within that response.

"The adaptive immune system is proving one of the most compelling and fascinating in the body," Professor Hodgkin said. "This system underlies our primary defense against acute infection and mediates long-term immunity by generating memory and long-lived effector cells. It is notorious for its complexity.

"Many diseases are associated with dysregulation of the adaptive immune system, including autoimmune conditions, cancer, allergies and immuno-deficiencies. A better understanding of this system would clearly bring health benefits so we will be examining B cell and T cell biology at three levels: the molecular, the cellular, and the whole animal; in the hope of delivering these benefits."

The development grants awarded to the institute will support Dr Chris Burns, who is trying to develop new treatments for rheumatoid arthritis; and Dr Krystal Evans, who is working to develop a new vaccine against the blood stage of the malaria parasite.

Dr Evans said it was estimated that around 3.5 billion people, approximately half of the world's population, live at risk of malaria infection. "There is currently a strong commitment to eliminate malaria in the 21st century. However, it is unlikely that this ambitious goal will be achieved without an effective vaccine," Dr Evans said. "As with smallpox and polio, we believe that a live attenuated vaccine would represent an invaluable tool for malaria elimination."

Dr Evans plans to manufacture a live genetically attenuated parasite blood-stage malaria vaccine, and use it in clinical trials to determine the safety and effectiveness of the vaccine.


'/>"/>
Contact: Penny Fannin
fannin@wehi.edu.au
61-417-125-700
Walter and Eliza Hall Institute
Source:Eurekalert

Related medicine news :

1. Germ in Cat Feces May Affect Human Brain, Behavior: Study
2. New MRI technology to provide even better images of the inside of the human body
3. Mans best friend: Common canine virus may lead to new vaccines for deadly human diseases
4. Pathway identified in human lymphoma points way to new blood cancer treatments
5. Pilot facility launched in Ghana to transform human waste into renewable biodiesel fuel
6. Human Intellect Backsliding From Lack of Evolutionary Pressure: Study
7. Human umbilical cord blood cell co-culture supports embryonic stem cell expansion
8. Sociology, economics researchers receive grant to study development across the human lifespan
9. Gut Bacteria Often Similar in Humans, Chimps: Study
10. First trial in humans of minicells: A completely new way of delivering anti-cancer drugs
11. Testing pain killers on humans could save money and speed the arrival of new drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2017)... ... 2017 , ... Patients interested in receiving quick and effective ... Cameron, with or without a referral. The FASTBRACES system is valued for its ... patient’s case, treatment with the FASTBRACES system could be completed in 120 days ...
(Date:3/29/2017)... Md., and MINNETONKA, Minn. (PRWEB) , ... March ... ... the development of medical office buildings (MOBs) and other outpatient facilities, and who ... project to look exclusively at those questions, Revista and Healthcare Real Estate Insights ...
(Date:3/29/2017)... ... March 29, 2017 , ... An inventor ... "The rubber bands used in conjunction with my braces always rubbed against the ... a way to prevent this problem." The O.B.S. was the result of his ...
(Date:3/29/2017)... ... March 29, 2017 , ... Immunotherapy has emerged as one of ... and is touted to be the next revolution in our fight against this complex ... the form of immune checkpoint inhibitors such as PD-1 and PD-L1 inhibitors. , While ...
(Date:3/29/2017)... ... March 29, 2017 , ... Physicians’ Education Resource® (PER®), will ... education conference for clinicians who manage some of the most difficult-to-treat forms of ... The program will be led by co- chairs Dr. John Marshall, chief of ...
Breaking Medicine News(10 mins):
(Date:3/30/2017)... Revenue Prospects by Product Type (Metered Dose Inhalers, Dry Powder ... Respiratory Inhalers - our new study reveals trends, R&D progress, and ... you are involved in this sector you must read this brand ... streams to 2027, assessing data, trends, opportunities and business prospects there. ... Discover how to ...
(Date:3/29/2017)... 29, 2017  Bodycad announced today that it ... 510(k) clearance for its Bodycad Unicompartmental Knee System, ... orthopaedic restoration. Bodycad is the first Canadian company ... implant system. Bodycad,s revolutionary Unicompartmental ... of the patient,s unique anatomical features and kinematics. ...
(Date:3/29/2017)... , March 29, 2017 Global intravenous (IV) iron ... billion by 2021, growing at a CAGR of 5%. ... by a doctor to treat anemia or other iron deficiencies. ... in the body. However, in some cases, oral administrations are ... and intravenous (IV) iron therapy comes into the picture. ...
Breaking Medicine Technology: